Nefense, a developer of advanced clinical hygiene and airway health solutions, has announced the official launch of its Hypochlorous Acid (HOCl) nasal spray line. The product expansion introduces an age-specific approach to airway health, respiratory hygiene, and nasal wellness, providing safe and effective nasal care solutions for adults, children, and infants.
The flagship Hyponasal spray delivers a gentle, clinical-grade biocleanse that flushes irritants, provides immediate soothing relief, and supports natural respiratory defenses without harsh chemicals or steroids. Powered by hypochlorous acid, the formulations offer broad-spectrum antimicrobial and anti-inflammatory action that neutralizes bacteria and viruses, helps prevent upper respiratory infections, and combats seasonal allergies.
According to the announcement, Nefense works in collaboration with doctors and ENT specialists to create innovative solutions that bridge the gap between daily hygiene, airway health, restorative sleep, and overall wellness. The company's growing portfolio includes XyloClean, a xylitol-based nasal spray designed to help moisturize and rebalance the nasal passages.
Many clinics and practices nationwide now offer in-store purchases of the Nefense nasal spray family. The launch of the HOCl nasal spray line marks a significant advancement in airway hygiene, particularly for vulnerable populations such as infants and children who require gentle yet effective solutions.
For more information, view the full announcement here.
